Japanese Pharmacology & Therapeutics(JPT)
Vol. 38 No. 11 2010
A new-generation uric acid production inhibitor febuxostat
―Comparison of the XO inhibition mechanism with allopurinol―
K. Okamoto
Jpn Pharmacol Ther 2010 38(11) 955-62
Enhancement of thioredoxin production by epinastine hydrochloride in vitro and in vivo
A. Furuta, et al.
Jpn Pharmacol Ther 2010 38(11) 965-70
Pectin improves iron bioavailability in gastrectomy-induced anemic rats
T. Miyada, et al.
Jpn Pharmacol Ther 2010 38(11) 971-9
M. Igarashi, et al.
Jpn Pharmacol Ther 2010 38(11) 981-6
SBN-024 optimal dose finding clinical study for allergic rhinitis
K. Okubo, et al.
Jpn Pharmacol Ther 2010 38(11) 987-96
Phase III general clinical study of SBN-024 for perennial allergic rhinitis
K. Okubo, et al.
Jpn Pharmacol Ther 2010 38(11) 997-1007
Phase III general clinical study of SBN-024 for seasonal allergic rhinitis
K. Okubo, et al.
Jpn Pharmacol Ther 2010 38(11) 1009-17
H. Akahori
Jpn Pharmacol Ther 2010 38(11) 1021-9
Y. Tomono, et al.
Jpn Pharmacol Ther 2010 38(11) 1031-40
H. Takeuchi, et al.
Jpn Pharmacol Ther 2010 38(11) 1041-50
K. Tsuda, et al.
Jpn Pharmacol Ther 2010 38(11) 1051-66